Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells. [PDF]
Hong M, Kedeshian K, Hoffman L, Kita A.
europepmc +1 more source
From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. [PDF]
Iațentiuc A +11 more
europepmc +1 more source
Establishment of a human inner ear model reveals that gentamicin C2b is substantially less ototoxic than clinical gentamicin. [PDF]
Jeong M +4 more
europepmc +1 more source
Nigella Sativa and Thymoquinone for Prevention or Mitigation of Acquired Sensorineural Hearing Loss: A Systematic Review. [PDF]
Horvath HL +5 more
europepmc +1 more source
Sex differences in response to kanamycin-induced ototoxicity in C57BL/6 J mice. [PDF]
Smith-Cortinez N +4 more
europepmc +1 more source
Computer models and artificial intelligence increase the fidelity and efficiency of the in vitro models for hearing loss. [PDF]
Iftode L +5 more
europepmc +1 more source
Determination of a New Biomarker at the Level of Gene Alteration in Cisplatin Ototoxicity. [PDF]
Kızmazoğlu D +7 more
europepmc +1 more source
Impact of pH on Intratympanic Sodium Thiosulfate-hyaluronan Gel in Preventing Cisplatin-induced Ototoxicity. [PDF]
Videhult Pierre P +2 more
europepmc +1 more source
Efficacy and safety of treatment regimens for drug-resistant tuberculosis in different regions: a systematic review and meta-analysis. [PDF]
Geng X +5 more
europepmc +1 more source

